Vimta Labs Ltd Quarterly Results
Q3 FY24-25 Results Summary
Revenue
The revenue stands at ₹89.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.11 per cent from ₹84.74 crore. This corresponds to a year-on-year *(YoY) growth of 20.57 per cent.
Operating Profit
Operating Profit stands at ₹33.08 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.60 per cent from ₹28.13 crore. This corresponds to a year-on-year *(YoY) growth of 51.88 per cent.
PBDT
PBDT stands at ₹37.71 crore, reflecting a quarter-on-quarter *(QoQ) increase of 32.69 per cent from ₹28.42 crore. This corresponds to a year-on-year *(YoY) growth of 71.80 per cent.
Profit Before Tax
Profit Before Tax stands at ₹27.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 38.60 per cent from ₹20.13 crore. This corresponds to a year-on-year *(YoY) growth of 106.36 per cent.
Net Profit
Net Profit stands at ₹21.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 40.98 per cent from ₹15.25 crore. This represents a 112.24 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Vimta Labs Ltd Earnings
- YOY
- QOQ
Vimta Labs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Vimta Labs Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Vimta Labs Ltd Financial Reports
Vimta Labs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Vimta Labs | -0.54% | 2.00% | -0.42% | 3.48% | 46.74% | -16.11% |
| Kovai Medical | -0.62% | -0.40% | 3.24% | 0.68% | 17.43% | -3.66% |
| Artemis Medicare | 0.71% | 2.66% | 3.49% | 28.08% | 52.84% | 40.06% |
| Indrapr.Medical | -1.08% | -0.52% | -2.78% | -7.07% | -7.79% | -20.94% |
| KMC Speciality | -0.65% | 1.59% | 14.68% | 37.18% | 98.51% | 140.57% |
| Dr Agarwal's Eye | -1.23% | -2.28% | -3.21% | 2.49% | 9.00% | 9.61% |
| Suraksha Diagno. | 1.44% | 6.72% | 8.63% | 29.44% | 36.53% | 13.36% |
Company Info
Company Information
Executive Chairman : S P Vasireddi
Managing Director : Harita Vasireddi
Independent Non Exe. Director : Y Prameela Rani
Independent Non Exe. Director : G Purnachandra Rao
Executive Director (Operation) : V Harriman
Executive Director : Satya Sreenivas Neerukonda
Independent Non Exe. Director : Sanjay Dave
Independent Non Exe. Director : Yadagiri R Pendri
Company Sec. & Compli. Officer : Sujani Vasireddi